Notice of Intent for Service and Maintenance for 2 BD LSR Fortessa Flow Cytometer Systems
Closed Special Notice Posted
- Solicitation number
- NIH-NCI-0819
- Agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 811210 Electronic and Precision Equipment Repair and Maintenance
- Place of performance
- Bethesda, Maryland, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, National Cancer Institute, Center for Cancer Research is issuing a sole-source Notice of Intent for preventative maintenance and service of two BD LSR Fortessa Flow Cytometer Systems, with response deadline August 19, 2026 and anticipated award the same date. This is a sole-source procurement; BD Biosciences is the only vendor determined capable of supplying the required services, including instrument software revisions, OEM-certified parts, and factory-trained technician labor. Performance runs September 6, 2026 through September 5, 2027 at the National Cancer Institute in Building 10, Bethesda, Maryland. Maintenance must be delivered by an OEM-Authorized Service Provider using OEM-certified factory-trained technicians. The acquisition is classified under NAICS 811210 (Electronic and Precision Equipment Repair and Maintenance) and carries a $34 million size standard; it is not set-aside for small business. Interested parties may submit capability statements, proposals, or quotations by August 19, 2026 to Deborah Blyveis, Contract Specialist, at deborah.blyveis@hhs.gov. Offerors must maintain active SAM registration and provide unit pricing, list pricing, shipping costs, delivery period, payment discount terms, F.O.B. point, DUNS number, Unique Entity ID, Taxpayer Identification Number, and business size certification.
Notice text
In accordance with the Federal Acquisition Regulations including the provisions set forth in FAR Subpart 5.101(a): the U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Center for Immuno-Oncology (CIO) intends to solicit on a sole-source basis (by a request for quotation to USBDB Service Contract Admin (BD Biosciences)) maintenance services for 2 BD LSR Fortessa Flow Cytometer Systems on or around August 4, 2026 with an award issued on or around August 19, 2026. The purpose of this acquisition is to acquire preventative maintenance and service for two existing BD LSR Fortessa Flow Cytometer Systems that was originally manufactured by BD Biosciences. These maintenance services shall be provided by an Original Equipment Manufacturer (OEM)-Authorized Service Provider of the LSR Fortessa Flow Cytometer, and all maintenance services shall be performed by OEM certified factory-trained technicians using OEM certified parts. In addition, BD Biosciences is the only provider that can supply instrument software revisions. This Sole Source Determination is based on HHS’ determination that BD Biosciences is the only Vendor that provides the required services.
Files
| File | Type | Posted |
|---|---|---|
| NOI Sole Source.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity